Completed OBSERVATIONAL NCT01798420

Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation

The Impact of Corticosteroid Treatment on Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation

Sponsor: The Nazareth Hospital, Israel

Conditions Chronic Obstructive Pulmonary Disease Diabetes

Updated 6 times since 2017 Last updated: Feb 22, 2013 Started: Apr 30, 2012 Primary completion: Sep 30, 2012 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chronic Obstructive Pulmonary Disease and Diabetes, this trial is completed. The trial is conducted by The Nazareth Hospital, Israel and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Nazareth Hospital, Israel

Data source: The Nazareth Hospital, Israel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nzareth, Israel